Early intervention for treatment and prevention of colorectal carcinomatosis. A plan for individualized care

Surgical Oncology Clinics of North America

Volumn 21, Issue 4, 2012, Pages 689-703

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

Carcinomatosis; Colorectal cancer; Cytoreductive surgery; HIPEC; Intraperitoneal chemotherapy; Second look surgery

Indexed keywords

CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; COLORECTAL CARCINOMA; COLORECTAL CARCINOMATOSIS; COLORECTAL SURGERY; CYTOREDUCTIVE SURGERY; EARLY INTERVENTION; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC THERAPY; LONG TERM SURVIVAL; PALLIATIVE THERAPY; PATIENT CARE PLANNING; PERSONALIZED MEDICINE; PREOPERATIVE PERIOD; REVIEW;

ALGORITHMS; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; PATIENT CARE PLANNING; PERITONEAL NEOPLASMS; PROGNOSIS; SECOND-LOOK SURGERY; TIME FACTORS;

EID: 84866777688     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2012.07.009     Document Type: Review

References (36)

1. Deraco M., Elias D., Glehen O., et al. Peritoneal surface malignancy. Cancer: principles and practice of oncology 2011, 2081-2089. Lippincott Williams and Wilkins. 9th edition. V.T. DeVita, T. Lawrence, S.A. Rosenberg (Eds.).
2. Jacquet P., Sugarbaker P.H. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 1996, 15:49-58.
3. Sugarbaker P.H., Jablonski K.A. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995, 221:124-132.
4. da Silva R.G., Sugarbaker P.H. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 2006, 203:878-886.
5. Elias D., Gilly F., Boutitie F., et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010, 28:63-68.
6. Sugarbaker P.H., Graves T., DeBruijn E.A., et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacologic studies. Cancer Res 1990, 50:5790-5794.
7. Elias D., Goere D., Di Pietrantonio D., et al. Results of systemic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 2008, 247:445-450.
8. Hughes K.S., Scheele J., Sugarbaker P.H. Surgery for colorectal cancer metastatic to the liver: optimizing the results of treatment. Surg Clin North Am 1989, 69:339-359.
9. Wangensteen O.H. Cancer of the colon and rectum; with special reference to earlier recognition of alimentary tract malignancy; secondary delayed re-entry of the abdomen in patients exhibiting lymph node involvement; subtotal primary excision of the colon; operation in obstruction. Wis Med J 1949, 48:591-597.
10. Griffen W.O., Humphrey L., Sosin H. The prognosis and management of recurrent abdominal malignancies. Curr Probl Surg 1969, 1-43.
11. Sugarbaker P.H., Zamcheck N., Moore F.D. Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer. Cancer 1976, 38:2310-2315.
12. Steele G., Zamcheck N., Wilson R., et al. Results of CEA-initiated second-look surgery for recurrent colon cancer. Am J Surg 1980, 139:544-548.
13. Attiyeh F.F., Stearns M.W. Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer 1981, 47:2119-2125.
14. Minton J.P., Hoehn J.L., Gerber D.M., et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985, 55:1284-1290.
15. Goldberg R.M., Fleming T.R., Tangen C.M., et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Ann Intern Med 1998, 129:27-35.
16. Sugarbaker P.H., Gianola F.J., Speyer J.L., et al. Prospective randomized trial of intravenous versus intraperitoneal 5 fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985, 98:414-421.
17. Sugarbaker P.H. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Peritoneal carcinomatosis: principles of management 1996, 79-100. Kluwer, Boston. P.H. Sugarbaker (Ed.).
18. Alexander H.R., Allegra C.J., Lawrence T.S. Metastatic cancer to the liver. Cancer: principles and practice of oncology 2001, 2690-2713. JB Lippincott, Philadelphia. 6th edition. V.T. DeVita, S. Hellman, S.A. Rosenberg (Eds.).
19. Yan T.D., Black D., Savady R., et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006, 24:4011-4019.
20. Swanson R.S., Compton C.C., Stewart A.K., et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003, 10:65.
21. Rich T., Gunderson L.L., Galdabini J., et al. Clinical and pathologic factors influencing local failure after curative resection of carcinoma of the rectum and rectosigmoid. Cancer 1983, 52:1317-1327.
22. West N.P., Morris E.J., Rotimi O., et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 2008, 9:857-865.
23. Bokey E.L., Chapuis P.H., Dent O.F., et al. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 2003, 46:860-866.
24. Sugarbaker P.H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999, 43(Suppl):S15-S25.
25. Sugarbaker P.H., Gunderson L.L., Wittes R.E. Colorectal cancer. Cancer: principles and practice of oncology 1985, vol. 1:795-866. JB Lippincott, Philadelphia. 2nd editiion.
26. Rekhraj S., Aziz O., Prabhudesai S., et al. Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis. Ann Surg Oncol 2007, 15:60-68.
27. Elias D., Sideris L., Pocard M., et al. Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 2004, 11:274-280.
28. Elias D., Liberale G., Vernerey D., et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995, 221:124-132.
29. Sugarbaker P.H. Monitoring after resection of upper and lower gastrointestinal cancer. Surgery for gastrointestinal cancer: a multidisciplinary approach 1997, 87-95. Lippincott-Raven, Philadelphia. H.J. Wanebo (Ed.).
30. Sugarbaker P.H. Peritonectomy procedures. Surg Oncol Clin N Am 2003, 12:703-727.
31. Pestieau S.R., Sugarbaker P.H. Treatment of primary colon cancer with peritoneal carcinomatosis: a comparison of concomitant versus delayed management. Dis Colon Rectum 2000, 43:1341-1348.
32. Tentes AA, Spiliotis ID, Korakianitis OS, et al. Adjuvant perioperative intraperitoneal chemotherapy in locally advanced colorectal carcinoma: preliminary results. (in press).
33. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003, 21:3737-3743.
34. Glasziou P., Chalmers I., Rawlins M., et al. When are randomised trials unnecessary? picking signal from noise. BMJ 2007, 334:349-351.
35. Lennon A.M., Mulcahy H.E., Hyland J.M.P., et al. Peritoneal involvement in stage II colon cancer. Am J Clin Pathol 2003, 119:108-113.
36. Schott A., Vogel I., Krueger U., et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998, 227:372-379.